The leading conferences in genome editing, cell lines, protein therapeutics, and bioconjugation have come together to create a platform for research scientists, biologists, and bioengineers can discuss the latest breakthroughs, technologies, and discoveries.
Learn from the latest cases studies and new data on innovative process and product strategies to streamline and optimize cell line development.
IBC's Cell Line Development and Engineering conference will deliver:
Insights on how CRISPR, TALENS, and other genome editing technologies impact strategies for cell line development
Strategies for improving product quality, biosimilarity, clonality, and stability
Techniques for cell line development and medication for novel modalities and difficult-to-express proteins
Cases studies and new data on ensuring cell line authenticity and novel host cell lines
"This is an outstanding venue for bringing together experts in the field, vendors, scientists and other interested parties, and the collaborative and open environment has always been rewarding. This meeting is on my calendar every year!"- Gene Lee, Ph.D., Director, Protein and Cell Sciences, EMD Serono
Meet the 2016 Cell Line Advisory Board!
Michael Butler, Ph.D., Professor, Microbiology, University of Manitoba, Canada
Rodney Combs, M.S., Associate Research Fellow, Bioprocess R&D, Culture Process Development, World Wide Pharmaceutical Sciences, Pfizer Inc.
Pamela Hawley-Nelson, Ph.D., Associate Director, Process Cell Culture, MedImmune Inc.
Kelvin Lee, Ph.D., Gore Professor of Chemical Engineering, Delaware Biotechnology Institute Faculty Fellow, University of Delaware
Kevin McCarthy, Ph.D., Group Leader for Cell Sciences, EMD Serono Inc.
IBC Life Sciences is part of Informa PLC which operates at the heart of the Knowledge and Information Economy Phone: 800.390.4078Email: firstname.lastname@example.org